Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Edema”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Early research (Phase 1)Study completedNCT01997164
What this trial is testing

Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Regeneron Pharmaceuticals 20
Post-approval studies (Phase 4)Study completedNCT06591598
What this trial is testing

Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular EdemaNeovascular Age-related Macular Degeneration
Bayer 51
Testing effectiveness (Phase 2)Study completedNCT05919693
What this trial is testing

A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (NVAMD)Diabetic Macular Edema (DME)
EyeBiotech Ltd. 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07501052
What this trial is testing

Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Who this might be right for
Neovascular (Wet) Age-Related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema+1 more
Sam Chun Dang Pharm. Co. Ltd. 33
Very early researchActive Not RecruitingNCT05099094
What this trial is testing

VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Shanghai BDgene Co., Ltd. 3
Early research (Phase 1)Study completedNCT02530918
What this trial is testing

Study of DS-7080a for the Treatment of Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Daiichi Sankyo 56
Testing effectiveness (Phase 2)Temporarily pausedNCT05961007
What this trial is testing

Evaluation of IBI302 Injection in nAMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Innovent Biologics (Suzhou) Co. Ltd. 234
Testing effectiveness (Phase 2)Study completedNCT02571972
What this trial is testing

Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.

Who this might be right for
Wet Macular DegenerationAge-related Macular DegenerationDiabetic Macular Edema+1 more
Wills Eye 14
Not applicableStudy completedNCT06723288
What this trial is testing

A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 736
Early research (Phase 1)Study completedNCT05105607
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Healthy Participants

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Ashvattha Therapeutics, Inc. 16
Not applicableUnknownNCT05222633
What this trial is testing

Anti-VEGF in Real-world

Who this might be right for
Neovascular Age-related Macular EdemaDiabetic Macular EdemaChoroidal Neovascular Membrane+3 more
Wenbin Wei 1,000
Not applicableWithdrawnNCT06398080
What this trial is testing

An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Wet Age-related Macular Degeneration (AMD)Diabetic Macular Edema (DME)+1 more
Regeneron Pharmaceuticals
Post-approval studies (Phase 4)Ended earlyNCT04563299
What this trial is testing

Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Retina Vitreous Associates of Florida 10
Testing effectiveness (Phase 2)Study completedNCT02118831
What this trial is testing

Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF

Who this might be right for
Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
California Retina Consultants 56
Not applicableLooking for participantsNCT02669953
What this trial is testing

Aflibercept in Recurrent or Persistent CNV

Who this might be right for
Age Related Macular DegenerationIntravitreal InjectionsDiabetic Macular Edema
Medical University of Vienna 80
Not applicableLooking for participantsNCT07308639
What this trial is testing

DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)
Bayer 50,000
Not applicableNot Yet RecruitingNCT07481500
What this trial is testing

Speculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: A Randomized Trial of Pain, Procedure Time, Patient Satisfaction, and Safety

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Diabetic Macular EdemaRetinal Vein Occlusion+1 more
Jakkrit Juhong 120
Large-scale testing (Phase 3)Study completedNCT05989126
What this trial is testing

Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)

Who this might be right for
Diabetic Macular Edema (DME)Neovascular Age-Related Macular Degeneration (nAMD)
Regeneron Pharmaceuticals 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT06664502
What this trial is testing

A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular Edema (DME)Neovascular Age-related Macular Degeneration (NVAMD)BRVO - Branch Retinal Vein Occlusion
EyeBiotech Ltd. 38
Testing effectiveness (Phase 2)Looking for participantsNCT07205887
What this trial is testing

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Who this might be right for
Neovascular Age-Related Macular Degeneration (NVAMD)Branch Retinal Vein Occlusion (BRVO)
EyeBiotech Ltd. 160
Load More Results